Suppr超能文献

用于神经退行性疾病的干细胞疗法:干细胞如何穿越血脑屏障并归巢至大脑?

Stem Cell Therapy for Neurodegenerative Diseases: How Do Stem Cells Bypass the Blood-Brain Barrier and Home to the Brain?

作者信息

Chia Yvonne Cashinn, Anjum Clarice Evey, Yee Hui Rong, Kenisi Yenny, Chan Mike K S, Wong Michelle B F, Pan Shing Yi

机构信息

Baden R&D Laboratories GmbH, Germany.

Baden Research and Testing (Asia Pac) Sdn Bhd, Malaysia.

出版信息

Stem Cells Int. 2020 Sep 4;2020:8889061. doi: 10.1155/2020/8889061. eCollection 2020.

Abstract

Blood-brain barrier (BBB) is a term describing the highly selective barrier formed by the endothelial cells (ECs) of the central nervous system (CNS) homeostasis by restricting movement across the BBB. An intact BBB is critical for normal brain functions as it maintains brain homeostasis, modulates immune cell transport, and provides protection against pathogens and other foreign substances. However, it also prevents drugs from entering the CNS to treat neurodegenerative diseases. Stem cells, on the other hand, have been reported to bypass the BBB and successfully home to their target in the brain and initiate repair, making them a promising approach in cellular therapy, especially those related to neurodegenerative disease. This review article discusses the mechanism behind the successful homing of stem cells to the brain, their potential role as a drug delivery vehicle, and their applications in neurodegenerative diseases.

摘要

血脑屏障(BBB)是一个术语,用于描述由中枢神经系统(CNS)的内皮细胞(ECs)形成的高度选择性屏障,它通过限制跨血脑屏障的移动来维持中枢神经系统的内稳态。完整的血脑屏障对于正常脑功能至关重要,因为它维持脑内稳态、调节免疫细胞运输,并提供针对病原体和其他外来物质的保护。然而,它也会阻止药物进入中枢神经系统以治疗神经退行性疾病。另一方面,据报道干细胞能够绕过血脑屏障并成功归巢至脑内的靶标并启动修复,使其成为细胞治疗中一种有前景的方法,尤其是与神经退行性疾病相关的治疗。本文综述讨论了干细胞成功归巢至脑内的机制、它们作为药物递送载体的潜在作用以及它们在神经退行性疾病中的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4708/7487096/ce790fd06b6b/SCI2020-8889061.001.jpg

相似文献

1
Stem Cell Therapy for Neurodegenerative Diseases: How Do Stem Cells Bypass the Blood-Brain Barrier and Home to the Brain?
Stem Cells Int. 2020 Sep 4;2020:8889061. doi: 10.1155/2020/8889061. eCollection 2020.
3
Brain Drug Delivery: Overcoming the Blood-brain Barrier to Treat Tauopathies.
Curr Pharm Des. 2020;26(13):1448-1465. doi: 10.2174/1381612826666200316130128.
4
Aspect Ratio of PEGylated Upconversion Nanocrystals Affects the Cellular Uptake In Vitro and In Vivo.
Acta Biomater. 2022 Jul 15;147:403-413. doi: 10.1016/j.actbio.2022.05.029. Epub 2022 May 21.
5
Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
Curr Top Med Chem. 2020;20(30):2762-2776. doi: 10.2174/1568026620666200826122402.
6
Nanoparticles as Powerful Tools for Crossing the Blood-brain Barrier.
CNS Neurol Disord Drug Targets. 2023;22(1):18-26. doi: 10.2174/1871527321666220222092655.
7
Nanowired Drug Delivery Across the Blood-Brain Barrier in Central Nervous System Injury and Repair.
CNS Neurol Disord Drug Targets. 2016;15(9):1092-1117. doi: 10.2174/1871527315666160819123059.
8
Epigenetics in blood-brain barrier disruption.
Fluids Barriers CNS. 2021 Apr 6;18(1):17. doi: 10.1186/s12987-021-00250-7.
9
Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
Int J Pharm. 2019 Mar 25;559:360-372. doi: 10.1016/j.ijpharm.2019.01.056. Epub 2019 Feb 2.
10
The blood-brain barrier, a key bridge to treat neurodegenerative diseases.
Ageing Res Rev. 2023 Nov;91:102070. doi: 10.1016/j.arr.2023.102070. Epub 2023 Sep 11.

引用本文的文献

1
Protective Effect of Stem Cells from Toxicity Induced by Gulf War Illness (GWI) Serum in N2A Neuroblastoma Cells.
J Neurol Neuromedicine. 2021 Aug 20;6(1):26-31. doi: 10.29245/2572.942x/2021/1.1281.
2
3
Stem cell-based ischemic stroke therapy: Novel modifications and clinical challenges.
Asian J Pharm Sci. 2024 Feb;19(1):100867. doi: 10.1016/j.ajps.2023.100867. Epub 2023 Nov 10.
4
State of the Art and Future of Stem Cell Therapy in Ischemic Stroke: Why Don't We Focus on Their Administration?
Bioengineering (Basel). 2023 Jan 14;10(1):118. doi: 10.3390/bioengineering10010118.
6
A Historical Review of Brain Drug Delivery.
Pharmaceutics. 2022 Jun 16;14(6):1283. doi: 10.3390/pharmaceutics14061283.
9
Mesenchymal stem cells and their derived exosomes to combat Covid-19.
Rev Med Virol. 2022 Mar;32(2):e2281. doi: 10.1002/rmv.2281. Epub 2021 Aug 7.

本文引用的文献

2
Therapeutic Mesenchymal Stromal Cells for Immunotherapy and for Gene and Drug Delivery.
Mol Ther Methods Clin Dev. 2020 Jan 22;16:204-224. doi: 10.1016/j.omtm.2020.01.005. eCollection 2020 Mar 13.
3
Preclinical And Clinical Development Of Oncolytic Adenovirus For The Treatment Of Malignant Glioma.
Oncolytic Virother. 2019 Oct 24;8:27-37. doi: 10.2147/OV.S196403. eCollection 2019.
4
The blood-brain barrier and blood-tumour barrier in brain tumours and metastases.
Nat Rev Cancer. 2020 Jan;20(1):26-41. doi: 10.1038/s41568-019-0205-x. Epub 2019 Oct 10.
5
Understanding neurodegeneration after traumatic brain injury: from mechanisms to clinical trials in dementia.
J Neurol Neurosurg Psychiatry. 2019 Nov;90(11):1221-1233. doi: 10.1136/jnnp-2017-317557. Epub 2019 Sep 21.
6
Targeting Autophagy for the Treatment of Alzheimer's Disease: Challenges and Opportunities.
Front Mol Neurosci. 2019 Aug 22;12:203. doi: 10.3389/fnmol.2019.00203. eCollection 2019.
7
Mesenchymal Stromal Cell Homing: Mechanisms and Strategies for Improvement.
iScience. 2019 May 31;15:421-438. doi: 10.1016/j.isci.2019.05.004. Epub 2019 May 9.
8
Mesenchymal stem cells for hemorrhagic stroke: status of preclinical and clinical research.
NPJ Regen Med. 2019 May 13;4:10. doi: 10.1038/s41536-019-0073-8. eCollection 2019.
9
Age-Associated Changes in the Immune System and Blood⁻Brain Barrier Functions.
Int J Mol Sci. 2019 Apr 2;20(7):1632. doi: 10.3390/ijms20071632.
10
Concise Review: Skeletal Muscle as a Delivery Route for Mesenchymal Stromal Cells.
Stem Cells Transl Med. 2019 May;8(5):456-465. doi: 10.1002/sctm.18-0208. Epub 2019 Feb 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验